| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,049 |
18,527 |
$12.31M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,891 |
26,245 |
$9.77M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,925 |
6,445 |
$4.35M |
| G0378 |
Hospital observation service, per hour |
6,525 |
4,763 |
$2.96M |
| J2323 |
Injection, natalizumab, 1 mg |
1,047 |
824 |
$2.39M |
| J2350 |
Injection, ocrelizumab, 1 mg |
221 |
155 |
$1.96M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,025 |
6,391 |
$1.33M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
26,995 |
6,990 |
$1.12M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
32,494 |
8,137 |
$963K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,165 |
2,925 |
$693K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
11,877 |
3,668 |
$596K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
9,876 |
2,326 |
$570K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,424 |
6,456 |
$547K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,572 |
5,949 |
$394K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,361 |
2,177 |
$358K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
435 |
342 |
$342K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
12,433 |
3,930 |
$298K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
698 |
668 |
$264K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
40,822 |
31,828 |
$247K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
659 |
556 |
$244K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,806 |
11,601 |
$242K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,096 |
9,104 |
$205K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
973 |
868 |
$201K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,146 |
6,999 |
$196K |
| 71046 |
Radiologic examination, chest; 2 views |
8,244 |
7,687 |
$194K |
| OP710 |
|
3,249 |
2,530 |
$189K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,743 |
8,921 |
$183K |
| 80053 |
Comprehensive metabolic panel |
37,169 |
30,019 |
$164K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,767 |
1,702 |
$155K |
| OP270 |
|
19,586 |
15,917 |
$150K |
| OP379 |
|
1,866 |
1,751 |
$147K |
| 97161 |
|
3,377 |
2,995 |
$144K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,173 |
2,071 |
$138K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,533 |
6,424 |
$137K |
| 76830 |
Ultrasound, transvaginal |
1,300 |
1,247 |
$110K |
| 93976 |
|
1,284 |
1,231 |
$105K |
| 71045 |
Radiologic examination, chest; single view |
6,819 |
5,989 |
$104K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,436 |
4,128 |
$97K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,422 |
2,140 |
$97K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,070 |
1,814 |
$91K |
| 36415 |
Collection of venous blood by venipuncture |
36,931 |
31,189 |
$80K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
583 |
528 |
$78K |
| OP370 |
|
1,166 |
888 |
$77K |
| 97162 |
|
1,471 |
1,333 |
$76K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,315 |
8,244 |
$74K |
| 97116 |
|
4,965 |
2,031 |
$73K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,054 |
992 |
$63K |
| OP272 |
|
5,830 |
4,380 |
$62K |
| 84484 |
|
9,614 |
7,230 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,581 |
3,264 |
$58K |
| 81003 |
|
22,753 |
20,143 |
$56K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,698 |
5,452 |
$52K |
| OP250 |
|
40,907 |
16,271 |
$50K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,131 |
962 |
$47K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,415 |
1,962 |
$47K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
434 |
331 |
$46K |
| 73562 |
|
1,465 |
1,349 |
$46K |
| 90839 |
|
2,485 |
2,247 |
$43K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,690 |
5,181 |
$42K |
| 93971 |
|
689 |
627 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,469 |
4,252 |
$40K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,302 |
1,236 |
$39K |
| 59025 |
Fetal non-stress test |
227 |
141 |
$39K |
| 74018 |
|
1,778 |
1,676 |
$38K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,715 |
8,848 |
$37K |
| 97113 |
|
561 |
202 |
$37K |
| 96415 |
|
342 |
258 |
$36K |
| 85610 |
|
8,484 |
7,292 |
$35K |
| 73630 |
|
1,386 |
1,307 |
$35K |
| 72110 |
|
561 |
529 |
$33K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,234 |
7,653 |
$33K |
| 73610 |
|
1,304 |
1,220 |
$32K |
| 73030 |
|
1,133 |
1,031 |
$32K |
| 85730 |
|
7,488 |
6,596 |
$32K |
| 94060 |
|
246 |
212 |
$32K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
968 |
880 |
$32K |
| 80061 |
Lipid panel |
4,669 |
4,277 |
$28K |
| A0425 |
Ground mileage, per statute mile |
708 |
678 |
$27K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,345 |
883 |
$27K |
| OP259 |
|
14,451 |
10,342 |
$27K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
479 |
430 |
$26K |
| 87088 |
|
6,017 |
5,718 |
$26K |
| OP258 |
|
21,691 |
15,737 |
$25K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,083 |
1,014 |
$25K |
| 86900 |
|
2,685 |
2,287 |
$24K |
| 73130 |
|
728 |
676 |
$23K |
| 87040 |
|
3,922 |
3,568 |
$20K |
| 83880 |
|
2,124 |
1,820 |
$19K |
| 87070 |
|
7,039 |
6,797 |
$19K |
| 93970 |
|
203 |
180 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,067 |
6,827 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,306 |
3,996 |
$18K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
237 |
180 |
$18K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
718 |
703 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,113 |
1,034 |
$17K |
| 83605 |
|
2,502 |
2,024 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
718 |
703 |
$15K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,833 |
5,030 |
$15K |
| 96376 |
|
1,947 |
1,335 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,495 |
1,365 |
$15K |
| 82077 |
|
4,163 |
3,174 |
$15K |
| 73110 |
|
438 |
408 |
$14K |
| 83690 |
|
6,621 |
5,911 |
$14K |
| 86850 |
|
2,376 |
2,013 |
$14K |
| 87186 |
|
2,197 |
1,968 |
$13K |
| 87077 |
|
2,184 |
1,962 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
234 |
222 |
$12K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
729 |
678 |
$12K |
| 83735 |
|
4,434 |
3,236 |
$12K |
| 76536 |
|
113 |
105 |
$12K |
| 97535 |
Self-care/home management training, each 15 minutes |
293 |
149 |
$11K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
12 |
12 |
$10K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,216 |
1,704 |
$10K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
503 |
491 |
$8K |
| 73502 |
|
337 |
312 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,326 |
1,132 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
111 |
108 |
$7K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
414 |
372 |
$7K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
310 |
305 |
$7K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
341 |
324 |
$7K |
| 84703 |
|
4,869 |
4,548 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,282 |
4,376 |
$7K |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
197 |
193 |
$6K |
| 72050 |
|
144 |
135 |
$6K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
12 |
12 |
$6K |
| 94729 |
|
163 |
144 |
$6K |
| 82607 |
|
1,117 |
986 |
$5K |
| 86140 |
|
5,009 |
4,602 |
$5K |
| 76642 |
|
75 |
62 |
$5K |
| 85027 |
|
3,425 |
2,639 |
$5K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
17 |
14 |
$5K |
| 80320 |
|
403 |
343 |
$5K |
| 86769 |
|
165 |
159 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
1,367 |
1,182 |
$4K |
| 84702 |
|
902 |
786 |
$4K |
| 85378 |
|
2,656 |
2,444 |
$4K |
| 80143 |
|
1,086 |
950 |
$4K |
| 84100 |
|
2,097 |
1,490 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
81 |
78 |
$4K |
| 90715 |
|
773 |
715 |
$4K |
| 82150 |
|
1,959 |
1,862 |
$4K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
90 |
79 |
$3K |
| 80179 |
|
1,073 |
942 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,206 |
925 |
$3K |
| 12001 |
|
54 |
50 |
$3K |
| 81025 |
|
2,623 |
2,462 |
$3K |
| 74021 |
|
69 |
69 |
$3K |
| 82728 |
|
679 |
616 |
$3K |
| 82550 |
|
1,374 |
1,199 |
$3K |
| 84439 |
|
843 |
769 |
$3K |
| 80164 |
|
206 |
178 |
$3K |
| 72100 |
|
170 |
154 |
$3K |
| 86480 |
|
51 |
51 |
$3K |
| 70486 |
|
33 |
29 |
$2K |
| 80329 |
|
141 |
128 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28 |
28 |
$2K |
| 73590 |
|
88 |
81 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
29 |
26 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
873 |
743 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,941 |
3,144 |
$2K |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
944 |
791 |
$2K |
| 85651 |
|
1,830 |
1,627 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
14 |
14 |
$2K |
| 51701 |
|
75 |
65 |
$2K |
| 93017 |
|
12 |
12 |
$2K |
| 96367 |
|
203 |
128 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
145 |
140 |
$2K |
| 73080 |
|
84 |
83 |
$2K |
| 82247 |
|
574 |
330 |
$2K |
| 86901 |
|
87 |
78 |
$2K |
| 86780 |
|
154 |
149 |
$2K |
| 83540 |
|
603 |
538 |
$2K |
| 97165 |
|
29 |
26 |
$2K |
| 94726 |
|
28 |
25 |
$2K |
| 86618 |
|
180 |
180 |
$1K |
| 73140 |
|
127 |
124 |
$1K |
| 82272 |
|
63 |
62 |
$1K |
| 72070 |
|
31 |
28 |
$1K |
| 83550 |
|
204 |
192 |
$1K |
| G0379 |
Direct admission of patient for hospital observation care |
303 |
250 |
$1K |
| 82043 |
|
632 |
608 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
696 |
504 |
$1K |
| 83518 |
|
685 |
668 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
282 |
243 |
$1K |
| 76775 |
|
12 |
12 |
$1K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
105 |
87 |
$1K |
| 90686 |
|
156 |
156 |
$1K |
| 88342 |
|
85 |
73 |
$1K |
| 76870 |
|
12 |
12 |
$993.76 |
| 92523 |
|
12 |
12 |
$972.50 |
| 82746 |
|
198 |
184 |
$860.41 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
741 |
645 |
$837.09 |
| 88304 |
|
60 |
55 |
$797.11 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
330 |
286 |
$690.35 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14 |
13 |
$676.45 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
851 |
475 |
$638.20 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
17 |
14 |
$636.14 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
62 |
59 |
$609.85 |
| 86309 |
|
387 |
374 |
$576.20 |
| 86665 |
|
52 |
52 |
$556.38 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
12 |
12 |
$546.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
780 |
530 |
$531.33 |
| J2060 |
Injection, lorazepam, 2 mg |
562 |
410 |
$488.99 |
| 83615 |
|
367 |
341 |
$483.81 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,475 |
1,334 |
$476.15 |
| 86803 |
|
41 |
34 |
$475.65 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
34 |
34 |
$449.70 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
12 |
12 |
$442.41 |
| 84550 |
|
495 |
418 |
$432.52 |
| 12011 |
|
14 |
12 |
$401.49 |
| 73090 |
|
43 |
41 |
$397.39 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
225 |
207 |
$389.68 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
221 |
195 |
$383.20 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
500 |
277 |
$378.19 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
829 |
728 |
$363.83 |
| 71101 |
|
17 |
12 |
$330.00 |
| 82248 |
|
79 |
68 |
$301.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
158 |
135 |
$292.96 |
| 86664 |
|
52 |
52 |
$234.64 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
536 |
468 |
$210.25 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
918 |
767 |
$203.03 |
| 84480 |
|
50 |
44 |
$164.01 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
678 |
572 |
$153.26 |
| 87205 |
|
27 |
26 |
$146.20 |
| 87420 |
|
50 |
48 |
$142.80 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
5,433 |
3,685 |
$121.15 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
12 |
12 |
$101.51 |
| 85007 |
|
68 |
60 |
$99.20 |
| 83655 |
|
13 |
12 |
$81.90 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
13 |
12 |
$74.10 |
| J1644 |
Injection, heparin sodium, per 1000 units |
207 |
102 |
$69.07 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
499 |
461 |
$44.15 |
| 81001 |
|
16 |
16 |
$35.94 |
| 82570 |
|
46 |
39 |
$34.50 |
| 81002 |
|
26 |
14 |
$26.00 |
| C1769 |
Guide wire |
32 |
24 |
$21.50 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
91 |
64 |
$14.95 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
22 |
22 |
$12.91 |
| J1815 |
Injection, insulin, per 5 units |
149 |
53 |
$12.65 |
| 87340 |
|
12 |
12 |
$6.04 |
| 80076 |
|
13 |
12 |
$3.99 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
12 |
12 |
$3.93 |
| J1630 |
Injection, haloperidol, up to 5 mg |
18 |
13 |
$3.35 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
16 |
12 |
$3.06 |
| 82962 |
|
221 |
146 |
$1.36 |
| J7510 |
Prednisolone oral, per 5 mg |
26 |
25 |
$1.00 |